The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gene signature predictor of dose-response to prostate radiation: Validation of PORTOS in phase III trials.
 
Shuang Zhao
Employment - Artera (I)
Stock and Other Ownership Interests - Exact Sciences (I)
Patents, Royalties, Other Intellectual Property - Patent applications pending (Inst); Patent applications pending licensed to Veracyte (Inst)
 
Hyunnam Ryu
No Relationships to Disclose
 
James Proudfoot
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Elai Davicioni
Employment - Veracyte
Stock and Other Ownership Interests - Veracyte
 
Jeff Michalski
Leadership - American Society of Therapeutic Radiation Oncology
Travel, Accommodations, Expenses - American Society of Therapeutic Radiation Oncology
 
Daniel Spratt
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Novartis; Pfizer
Research Funding - Janssen (Inst)
(OPTIONAL) Uncompensated Relationships - NCCN
 
Stefanie Hayoz
No Relationships to Disclose
 
Jeffry Simko
No Relationships to Disclose
 
Howard Sandler
Consulting or Advisory Role - Janssen
Other Relationship - Caribou Publishing
 
Alan Pollack
Research Funding - Varian Medical Systems
 
Matthew Parliament
No Relationships to Disclose
 
Ian Dayes
Honoraria - Verity Pharmaceuticals
 
Rohann Correa
Research Funding - Droplet Biosciences
 
Theodore Karrison
No Relationships to Disclose
 
William Hall
Stock and Other Ownership Interests - Sonoptima
Consulting or Advisory Role - Aktis Oncology; Sonoptima
Research Funding - Elekta (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for a wearable device for radiation treatment planning (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Daniel Aebersold
Leadership - SWAN Isotopen
Honoraria - Roche
Consulting or Advisory Role - Roche
Research Funding - Merck KGaA (Inst); Varian Medical Systems (Inst)
 
Felix Feng
Stock and Other Ownership Interests - Artera; Bluestar Genomics; Serimmune
Consulting or Advisory Role - Artera; Astellas Pharma; Bayer; BlueStar Genomics; Bristol Myers Squibb; Bristol Myers Squibb (BMS); Exact Sciences; Foundation Medicine; Janssen Biotech; Myovant Sciences; Novartis; POINT Biopharma; Roivant; SerImmune; Tempus; Varian Medical Systems
Research Funding - Zenith Epigenetics
 
Pirus Ghadjar
Consulting or Advisory Role - Dr. Sennewald Medizintechnik
Research Funding - Oncotherm (Inst)
 
Phuoc Tran
Honoraria - Reflexion Medical
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Health; Dendreon; GenomeDx; Janssen; Lantheus Medical Imaging; Myovant Sciences; Noxopharm; Reflexion Medical; Reflexion Medical; Regeneron
Research Funding - Astellas Pharma (Inst); Bayer Health (Inst); Reflexion Medical (Inst)
Patents, Royalties, Other Intellectual Property - Compounds and Methods of Use in Ablative Radiotherapy. Patent filed 3/9/2012. PCT/US2012/028475. PCT/WO/2012/122471.
Travel, Accommodations, Expenses - Reflexion Medical
 
Alan Dal Pra
Consulting or Advisory Role - Merck; Pfizer
Research Funding - Veracyte (Inst)